Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastric Emptying | 2 | 2023 | 233 | 0.850 |
Why?
|
Family Leave | 1 | 2021 | 18 | 0.830 |
Why?
|
Sick Leave | 1 | 2021 | 110 | 0.760 |
Why?
|
Diagnostic Techniques, Digestive System | 1 | 2020 | 47 | 0.750 |
Why?
|
Specialty Boards | 1 | 2021 | 227 | 0.710 |
Why?
|
Organizational Policy | 1 | 2021 | 427 | 0.680 |
Why?
|
Nuclear Medicine | 1 | 2020 | 233 | 0.590 |
Why?
|
Nanoparticles | 5 | 2021 | 1902 | 0.570 |
Why?
|
Radionuclide Imaging | 1 | 2020 | 2027 | 0.560 |
Why?
|
Pleural Neoplasms | 1 | 2020 | 607 | 0.510 |
Why?
|
Radiopharmaceuticals | 3 | 2020 | 2658 | 0.510 |
Why?
|
Pancreatic Pseudocyst | 1 | 2014 | 110 | 0.500 |
Why?
|
Vascular Fistula | 1 | 2014 | 50 | 0.500 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2020 | 2028 | 0.470 |
Why?
|
Pancreatic Fistula | 1 | 2014 | 145 | 0.470 |
Why?
|
Molecular Imaging | 1 | 2020 | 831 | 0.440 |
Why?
|
Cyclodextrins | 1 | 2013 | 57 | 0.440 |
Why?
|
Magnetic Resonance Imaging | 9 | 2021 | 35342 | 0.420 |
Why?
|
Portal Vein | 1 | 2014 | 437 | 0.410 |
Why?
|
Tumor Microenvironment | 3 | 2022 | 3564 | 0.390 |
Why?
|
Parental Leave | 3 | 2021 | 78 | 0.390 |
Why?
|
Colon | 1 | 2019 | 1773 | 0.380 |
Why?
|
Camptothecin | 1 | 2013 | 572 | 0.350 |
Why?
|
Positron-Emission Tomography | 6 | 2021 | 6259 | 0.350 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2013 | 623 | 0.340 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 2217 | 0.320 |
Why?
|
Students, Medical | 1 | 2020 | 1858 | 0.290 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13655 | 0.290 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2522 | 0.290 |
Why?
|
Neoplasms | 4 | 2022 | 21596 | 0.270 |
Why?
|
Lymphoma | 1 | 2013 | 1873 | 0.240 |
Why?
|
MAP Kinase Signaling System | 2 | 2021 | 1525 | 0.230 |
Why?
|
Internship and Residency | 2 | 2020 | 5774 | 0.220 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4229 | 0.210 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2013 | 2736 | 0.200 |
Why?
|
Gastroparesis | 1 | 2023 | 131 | 0.200 |
Why?
|
Cheese | 1 | 2020 | 38 | 0.190 |
Why?
|
Contrast Media | 3 | 2020 | 5295 | 0.190 |
Why?
|
Ferric Compounds | 2 | 2013 | 374 | 0.190 |
Why?
|
Eggs | 1 | 2020 | 184 | 0.170 |
Why?
|
Copper Radioisotopes | 3 | 2018 | 86 | 0.170 |
Why?
|
Ferrosoferric Oxide | 1 | 2020 | 360 | 0.170 |
Why?
|
Technetium Tc 99m Medronate | 1 | 2019 | 134 | 0.170 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2021 | 8925 | 0.170 |
Why?
|
Glucans | 1 | 2018 | 72 | 0.170 |
Why?
|
Antigen-Presenting Cells | 1 | 2022 | 969 | 0.160 |
Why?
|
Isotope Labeling | 1 | 2018 | 414 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20086 | 0.140 |
Why?
|
Cell Line, Tumor | 5 | 2022 | 16665 | 0.140 |
Why?
|
Motion | 1 | 2020 | 797 | 0.140 |
Why?
|
Neoplasms, Experimental | 1 | 2021 | 1274 | 0.130 |
Why?
|
Food | 1 | 2020 | 769 | 0.130 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2018 | 692 | 0.120 |
Why?
|
Immunity | 1 | 2020 | 1011 | 0.120 |
Why?
|
Parenting | 1 | 2020 | 676 | 0.120 |
Why?
|
Career Choice | 1 | 2020 | 743 | 0.120 |
Why?
|
Paclitaxel | 1 | 2021 | 1707 | 0.120 |
Why?
|
Algorithms | 5 | 2015 | 13853 | 0.120 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1683 | 0.120 |
Why?
|
Schools, Medical | 1 | 2020 | 878 | 0.110 |
Why?
|
Respiration | 1 | 2020 | 1645 | 0.110 |
Why?
|
Reference Values | 1 | 2020 | 4982 | 0.110 |
Why?
|
Permeability | 1 | 2015 | 738 | 0.110 |
Why?
|
Phantoms, Imaging | 2 | 2012 | 2466 | 0.110 |
Why?
|
Doxorubicin | 1 | 2018 | 2215 | 0.100 |
Why?
|
Faculty, Medical | 1 | 2020 | 1182 | 0.100 |
Why?
|
Mice | 8 | 2022 | 81045 | 0.100 |
Why?
|
Macrophages | 2 | 2018 | 5655 | 0.100 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1066 | 0.100 |
Why?
|
Autoradiography | 1 | 2012 | 749 | 0.100 |
Why?
|
Artifacts | 1 | 2020 | 1903 | 0.100 |
Why?
|
Macrophage Activation | 1 | 2013 | 558 | 0.090 |
Why?
|
Animals | 10 | 2022 | 168561 | 0.090 |
Why?
|
Nanomedicine | 1 | 2013 | 304 | 0.090 |
Why?
|
Caregivers | 1 | 2021 | 2074 | 0.090 |
Why?
|
Education, Medical, Graduate | 2 | 2020 | 2283 | 0.090 |
Why?
|
Fatal Outcome | 1 | 2014 | 1849 | 0.090 |
Why?
|
Calibration | 1 | 2012 | 815 | 0.090 |
Why?
|
Blood-Brain Barrier | 1 | 2015 | 1015 | 0.080 |
Why?
|
User-Computer Interface | 1 | 2015 | 1426 | 0.080 |
Why?
|
Humans | 17 | 2023 | 742088 | 0.080 |
Why?
|
Female | 10 | 2022 | 379592 | 0.080 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2014 | 1130 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14720 | 0.070 |
Why?
|
Tumor Burden | 1 | 2013 | 1905 | 0.070 |
Why?
|
Metal Nanoparticles | 1 | 2011 | 403 | 0.070 |
Why?
|
Mice, Nude | 1 | 2013 | 3689 | 0.070 |
Why?
|
Immunotherapy | 1 | 2022 | 4414 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3557 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4823 | 0.060 |
Why?
|
Image Enhancement | 1 | 2015 | 2921 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2022 | 10163 | 0.060 |
Why?
|
Antibodies | 1 | 2012 | 2459 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12958 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2012 | 2013 | 0.060 |
Why?
|
Light | 1 | 2009 | 1374 | 0.060 |
Why?
|
Food, Formulated | 1 | 2023 | 109 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3328 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5462 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18006 | 0.050 |
Why?
|
Pinocytosis | 1 | 2021 | 65 | 0.050 |
Why?
|
Software | 1 | 2015 | 4434 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2015 | 19862 | 0.050 |
Why?
|
Plaque, Atherosclerotic | 1 | 2011 | 1499 | 0.040 |
Why?
|
Mutation | 2 | 2021 | 29717 | 0.040 |
Why?
|
Child Care | 1 | 2020 | 119 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 21821 | 0.040 |
Why?
|
Surface Properties | 2 | 2013 | 1182 | 0.040 |
Why?
|
Adult | 4 | 2020 | 213712 | 0.040 |
Why?
|
Particle Size | 2 | 2013 | 1640 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 625 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 647 | 0.040 |
Why?
|
Lactation | 1 | 2020 | 412 | 0.040 |
Why?
|
Enteral Nutrition | 1 | 2023 | 763 | 0.040 |
Why?
|
Pelvis | 1 | 2021 | 730 | 0.040 |
Why?
|
Young Adult | 2 | 2020 | 56350 | 0.040 |
Why?
|
Models, Biological | 1 | 2013 | 9581 | 0.030 |
Why?
|
United States | 2 | 2021 | 69693 | 0.030 |
Why?
|
Child | 2 | 2023 | 77478 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2018 | 731 | 0.030 |
Why?
|
ras Proteins | 1 | 2020 | 1060 | 0.030 |
Why?
|
Male | 4 | 2020 | 349538 | 0.030 |
Why?
|
Middle Aged | 3 | 2020 | 213127 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57683 | 0.030 |
Why?
|
Software Design | 1 | 2015 | 176 | 0.030 |
Why?
|
Normal Distribution | 1 | 2015 | 280 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2018 | 13019 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1875 | 0.030 |
Why?
|
Needs Assessment | 1 | 2020 | 1146 | 0.030 |
Why?
|
Adolescent | 1 | 2020 | 85649 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2938 | 0.030 |
Why?
|
Dextrans | 1 | 2013 | 592 | 0.030 |
Why?
|
Time Factors | 2 | 2010 | 40054 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2018 | 14554 | 0.020 |
Why?
|
Aged | 2 | 2020 | 162944 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6382 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 824 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4391 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9735 | 0.020 |
Why?
|
Cell Line | 2 | 2013 | 15994 | 0.020 |
Why?
|
Signal Transduction | 2 | 2022 | 23387 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 2721 | 0.020 |
Why?
|
Materials Testing | 1 | 2011 | 865 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2015 | 1538 | 0.020 |
Why?
|
Kinetics | 1 | 2015 | 6474 | 0.020 |
Why?
|
Electrodes | 1 | 2009 | 615 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8662 | 0.020 |
Why?
|
Molecular Structure | 1 | 2011 | 1907 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 62966 | 0.020 |
Why?
|
Neurodegenerative Diseases | 1 | 2015 | 1060 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 3839 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5163 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2011 | 1438 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8425 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5522 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2011 | 1731 | 0.010 |
Why?
|
Computer Simulation | 1 | 2015 | 6191 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 2015 | 3076 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 29087 | 0.010 |
Why?
|
Infant | 1 | 2020 | 35070 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 40955 | 0.010 |
Why?
|
Rats | 1 | 2013 | 24265 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 77098 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2015 | 7988 | 0.010 |
Why?
|
Concepts
(164)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_